Abstract
It has become clear that superselective intraarterial infusion therapy has demonstrated extremely high effectiveness for advanced head and neck cancer in combination with radiation therapy. It is expected to contribute in particular to improvement of patients’ quality of life following treatment and improvement of the prognosis through organ preservation. However, some problems currently remain to be solved, such as indications or complications. We report herein on our cases and those in the literature, and discuss superselective intraarterial infusion therapy in Japan.
